Known targets — ChEMBL curated mechanism
CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D
The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.64 |
| ▸ | NPC1 | O15118 | 5/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.64 |
| ▸ | MITF | O75030 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.51 |
| ▸ | CES1 | P23141 | 1/20 | 0.51 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Guanidino-Benzoic Acid SCHEMBL28865466 | 0.95 | MEN1 (0.62) | MEN1KMT2ANPC1RAB9AMITF | |
| 4-Guanidino-Benzoic Acid SCHEMBL27610956 | 0.94 | MEN1 (0.64) | MEN1KMT2ANPC1RAB9AMITF | |
| SCHEMBL1740370 | 0.86 | KMT2A (0.63) | MEN1KMT2ANPC1RAB9AMITF | |
| Acetic Acid SCHEMBL27811416 | 0.85 | KMT2A (0.59) | MEN1KMT2ANPC1RAB9AMITF | |
| Hydrochloric Acid SCHEMBL7258086 | 0.85 | KMT2A (0.61) | MEN1KMT2ANPC1RAB9AMITF | |
| Nitric Acid SCHEMBL3860512 | 0.83 | KMT2A (0.59) | MEN1KMT2ANPC1RAB9AMITF | |
| Benzoic Acid SCHEMBL27557362 | 0.81 | TDP1 (0.83) | MEN1KMT2ANPC1RAB9AMITF | |
| SCHEMBL6967368 | 0.80 | KMT2A (0.69) | MEN1KMT2ANPC1RAB9AMITF | |
| 4-Nitrobenzoic Acid SCHEMBL3850860 | 0.79 | TDP1 (0.88) | MEN1KMT2ANPC1RAB9AMITF | |
| 4-Guanidino-Benzoic Acid SCHEMBL211005 | 0.79 | F2 (0.57) | MEN1KMT2AMITFPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0879605-A2 | GLYCOSYL PRODRUG CONJUGATE WITH ENHANCED TOLERANCE | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-11-25 | — | — | EP | claimed |
| US-7838006-B2 | Viral vaccine composition, process and methods of use | IMMUNITOR USA INC. (US) | 2010-11-23 | — | — | US | disclosed |
| US-20090226489-A1 | VIRAL VACCINE COMPOSITION, PROCESS AND METHODS OF USE | IMMUNITOR USA INC. (US) | 2009-09-10 | — | — | US | disclosed |
| EP-0795334-B1 | Prodrugs for the treatment tumors and inflammatory diseases | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-02-01 | — | — | EP | disclosed |
| US-20050079218-A1 | Matrices for the stabilizing and controlled release of problematic substances | ACHIM GOPFERICH (DE) | 2005-04-14 | — | — | US | disclosed |
| EP-1453485-A2 | MATRICES FOR STABILIZING AND CONTROLLED RELEASE OF PROBLEMATIC SUBSTANCES | Göpferich, Achim, Prof. Dr. (DE) | 2004-09-08 | — | — | EP | disclosed |
| WO-2003049719-A2 | MATRICES FOR STABILIZING AND CONTROLLED RELEASE OF PROBLEMATIC SUBSTANCES | GOEPFERICH ACHIM (DE) | 2003-06-19 | — | — | WO | disclosed |
| US-20030092145-A1 | Viral vaccine composition, process, and methods of use | IMMUNITOR USA INC. | 2003-05-15 | — | — | US | disclosed |
| WO-2001054717-A1 | VACCINE COMPOSITION, PROCESS AND METHODS | JIRA VIC (US) | 2001-08-02 | — | — | WO | disclosed |
| US-6020315-A | Preparation having increased in vivo tolerability | HOECHST AKTIENGESELLSCHAFT (DE) | 2000-02-01 | — | — | US | disclosed |
| US-5935995-A | POLY-, OLIGO- AND MONOSACCHARIDES OF DRUGS, E.G. NITROGEN MUSTARD GAS, QUININE AND DIPYRIDAMOLE; STABILITY; SLOW RELEASE; ANTIARTHITIC AGENTS; ENZYME INHIBITORS | HEOCHST AKTIENGESELLSCHAFT (DE) | 1999-08-10 | — | — | US | disclosed |
| EP-0879605-A2 | GLYCOSYL PRODRUG CONJUGATE WITH ENHANCED TOLERANCE | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-11-25 | — | — | EP | disclosed |
| EP-0795334-A2 | Prodrugs for the treatment tumors and inflammatory diseases | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-17 | — | — | EP | disclosed |